<DOC>
	<DOCNO>NCT02859142</DOCNO>
	<brief_summary>The purpose study learn combination study drug patch effective help heavy drinker stop smoke patch alone The study drug , varenicline , approve Food Drug Administration ( FDA ) help people stop smoking , know addition varenicline standard smoke cessation treatment nicotine patch help people stop smoking regular , frequent drinker . This study do cigarette smoke number one preventable cause death disease United States .</brief_summary>
	<brief_title>Varenicline Augmentation Patch Outcomes Heavy Drinkers ' Smoking Cessation</brief_title>
	<detailed_description>This study conduct real-world clinic-based smoking cessation trial examine augmentation strategy Chantix ( Varenicline Tartrate ) , nicotine patch , behavioral counsel versus standard treatment patch plus behavioral counseling heavy drinker smoke ( HDS ) . While Chantix approve smoke cessation , routinely give practice HDS patient In study , 4 total in-person study visit trial ( pre-quit , quit date , week 2 week 12 ) , end 12 week quit date . Biochemical verification breath test CO , well vital sign weight , measure visit along survey response measure smoke urge withdrawal , negative affect , neurocognition , alcohol smoking behavior . These also use 26-week follow-up telephone biochemical verification CO report smoke-free . Screening Randomization Participants respond advertisement undergo brief phone screen determine initial eligibility requirement . Qualified candidate invite lab conduct short screening study information session Clinical Addictions Research Laboratory University Chicago . At screen , participant sign inform consent document . Next , demographic , smoking , alcohol substance use pattern , health history , medication , vital sign , urine test ( pregnancy and/or drug toxicology ) blood test obtain . Eligible participant randomize one two treatment group : Standard Treatment proceed study receive nicotine patch brief counseling session ; Augmented Treatment proceed nicotine patch brief counseling session , also receive standard dose Chantix ( Varenicline tartrate ) . Nicotine Patches Nicotine patch utilize start study quit date , proceed accord package insert direction ( 10+ cigs/day smoker begin 21mg patch six week , follow 14mg patch four week , finally 7mg patch two week . Those smoke few 10 cigarettes/day follow process start 14mg patch level . Chantix ( Varenicline Tartrate ) Those receive Augmented Treatment receive varenicline effectiveness study . They undergo up-titration week prior quit date , 12 week target dosing , down-titration week . As per Pfizer recommendation , up-titration 0.5mg tablet daily 3 day follow twice daily four day lead quit date day 8 . The sequence reverse down-titration week week 13 . Smoking Cessation Behavioral Sessions : Participants attend one-on-one behavioral counseling session train Masters PhD . Level therapist study visit . Behavioral session involve teach behavioral skill assist smoke cessation , prevent relapse , cop physical emotional change associate craving . At study visit , subjective measure ( i.e . brief self-report survey Follow-Up Interview ( Week 26 ) At Study Week 26 , participant complete follow-up telephone interview , complete similar subjective measure complete study visit . Participants report smoke-free interview arrange biochemical verification status via expire CO test either arrange time stop one study sit arrange study staff meet home workplace .</detailed_description>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Alcoholic Intoxication</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Smoke 330 cigarettes/day Desire quit smoking indicate smoking stage ladder Consume &gt; 14 ( men ) &gt; 7 ( woman ) standard alcohol drink per week ( e.g. , 1 drink = 12 oz beer , 5 oz wine , 1.5 oz liquor ) Ability understand , read , write English , least 8th grade education Willing able sign inform consent Stable residence contact information . Hepatic panel index &gt; 2 SD History seizures DTs alcohol withdrawal Unstable medical ( e.g. , hepatitis , cirrhosis , seizure disorder , recent major cardiovascular event , etc . ) psychiatric disorder ( e.g. , active hallucination , severe depression , obsessional thinking , selfinjury risk significant blood loss , etc . ) deem study physician significant risk adverse interaction study medication measure . History adverse reaction varenicline ( VAR ) nicotine patch Current suicidal ideation ( past 6 month ) and/or history major suicide attempt . For woman childbearing potential : currently pregnant , lactate , current plan become pregnant next three month , unable agree adequate birth control study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Varenicline</keyword>
</DOC>